CCM Duopharma Biotech may rise higher after it formed a second consecutive white candle and leaving an upside gap. This close has sent the stock to its highest close in more than three months, thereby enhancing the positive sentiment. A bullish bias may emerge above the MYR1.07 level, with an exit set below the MYR1.01 threshold. Towards the upside, the immediate resistance is at MYR1.16. This is followed by the MYR1.25 level.

Source: RHB Securities Research - 20 Feb 2019